Greenwich LifeSciences
GLSI
39 hedge funds and large institutions have $16.4M invested in Greenwich LifeSciences in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 3 closing their positions.
351% more capital inflows, than outflows
Capital inflows: $2.22M | Capital outflows: $491K
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
15% more funds holding
Funds holding: 34 → 39 (+5)
0.75% more ownership
Funds ownership: 7.93% → 8.67% (+0.75%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$744K |
| 2 |
BlackRock
New York
|
+$611K |
| 3 |
Millennium Management
New York
|
+$158K |
| 4 |
Morgan Stanley
New York
|
+$148K |
| 5 |
STRS Ohio
Columbus,
Ohio
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$287K |
| 2 |
Renaissance Technologies
New York
|
-$65.2K |
| 3 |
Bank of New York Mellon
New York
|
-$60.6K |
| 4 |
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$32.8K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$29.6K |
GLSI Hedge Fund Activity: Q3 2024 in Review
39 of the 6,985 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q3 2024, worth a combined $16.4M — down 7% from $17.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new GLSI positions and 3 closed out — a net gain of 5 holders — while 13 added to existing stakes and 8 trimmed.
The largest buyer was Northern Trust, adding an estimated $744K. The largest seller was Man Group, exiting entirely with an estimated $287K sold.
- 39 institutional investors held Greenwich LifeSciences (GLSI) as of Q3 2024, up from 34 in Q2 2024.
- Funds reported $16.4M of Greenwich LifeSciences stock for Q3 2024, down 7% quarter-over-quarter.
- 8 funds opened new Greenwich LifeSciences positions in Q3 2024 and 3 closed out, a net change of +5 holders.
- The largest Greenwich LifeSciences buyer in Q3 2024 was Northern Trust, an estimated $744K added.
- The largest Greenwich LifeSciences seller in Q3 2024 was Man Group, an estimated $287K sold.
Based on aggregated 13F filings for Q3 2024.